title: Evaluation of the potential antidepressant effects of soybean isoflavones.
abstract: The aim of the study was to determine whether isoflavones affect depressive symptoms in women.
  
  
  
  Literature searches were conducted to identify clinical and epidemiologic studies that evaluated the impact of soy intake and isoflavone exposure on depressive symptoms. References from identified studies were also evaluated to identify eligible studies.
  
  
  
  Only limited epidemiologic research has evaluated the impact of soy or isoflavone intake on depression although several studies from China and Japan did find soy product intake was inversely related to risk of depression. Often times, soy was, however, evaluated only as a component of a summative dietary pattern (eg, a "Japanese" or "Healthy" diet). Of the 20 intervention studies identified, roughly half found statistically significant reductions in depressive symptoms in response to isoflavones although several had design weakness. Of those studies reporting a lack of antidepressant effects of isoflavones, design limitations likely contributed to the lack of efficacy. In all but two trials, assessment of depression was, however, a secondary outcome. It is notable that both trials in which depression was a primary outcome found isoflavones significantly improved symptoms.
  
  
  
  Although the data are inconsistent and limited, the clinical and epidemiologic evidence suggests that isoflavones may offer a safe, well-tolerated option for management of depression. Furthermore, the intervention doses used in the clinical studies fall well within the dietary range. The extant literature reveals key design features for future studies, which based upon the results of this review, are clearly warranted.
authors.affiliation: 1Nutrition Matters, Inc, Pittsfield, MA 2University of Wisconsin School of Medicine and Public Health, Madison, WI.
authors.forename: Mark
authors.initials: M
authors.lastname: Messina
authors.forename: Carey
authors.initials: C
authors.lastname: Gleason
mesh_terms: D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007529:Isoflavones / Q000627:therapeutic use*; D008875:Middle Aged; D008517:Phytotherapy / Q000379:methods*; D030262:Soybean Proteins / Q000627:therapeutic use*; D013025:Glycine max / Q000737:chemistry
chemical_list: D000928:Antidepressive Agents; D007529:Isoflavones; D030262:Soybean Proteins